Related by context. All words. (Click for frequent words.) 81 Patent Covering 73 RNAi Therapeutics 71 Patents Covering 70 Receives Orphan Drug Designation 69 Fast Track Status 69 Patent Issued 69 Psoriasis Drug 68 Drug Candidate 68 Files IND 68 Expanded Indication 68 Immunomedics Announces 68 Exclusive License 68 RNAi Therapeutic 68 Systemic Delivery 68 Receives Patent 67 Gout Drug 67 GRAS Status 67 Schizophrenia Drug 67 Orphan Status 67 Epilepsy Drug 67 FDA Accepts 66 Prostate Cancer Vaccine 66 Receives Milestone Payment 66 Presents Preclinical Data 66 Receives Orphan Drug 66 Clinical Trial Results 66 Patient Enrollment 66 Initiates Clinical 66 Meets Primary Endpoint 66 Small Molecule 66 Tumor Targeting 66 Prolongs Survival 66 IND Application 66 Phase 2a Trial 66 Granted Orphan Drug 66 NDA Submission 66 Patient Enrolment 66 Present Preclinical Data 66 Investigational Compound 66 Malaria Vaccine 66 Collaborators Publish 66 Phase IIb Clinical Trial 66 Lung Cancer Drug 65 Initiates Clinical Trial 65 Smallpox Vaccine 65 Testosterone Gel 65 Phase III Clinical Trial 65 Lupus Drug 65 Data Suggest 65 Preclinical Data 65 Mylan Receives Approval 65 Completes Patient Enrollment 65 Begin Clinical Trials 65 Anti Tumor 65 Issued Patent 65 Stem Cell Treatment 65 Positive Opinion 65 Seasonal Influenza Vaccine 65 Teva Provides Update 65 Arthritis Drug 65 Improves Survival 65 Significantly Improves 64 Develop Novel 64 DOR BioPharma Announces 64 Generic Version 64 Rheumatoid Arthritis Drug 64 Pivotal Phase III 64 Lorus Therapeutics Announces 64 Therapeutic Competitors Companies 64 Significantly Improved 64 Milestone Payment 64 FDA Clearance 64 Single Dose 64 Cholesterol Lowering Drug 64 Initiates Phase III 64 Demonstrates Ability 64 Phase III Trial 64 Novel Vaccine 64 Submits NDA 64 Vaccine Candidate 64 Novel Oral 64 Transdermal Drug 64 PDUFA Date 64 Aztreonam Lysine 64 Phase IIb Trial 64 Oral Calcitonin 63 Migraine Drug 63 Molecular Mechanism 63 Pediatric Exclusivity 63 Pivotal Study 63 Therapeutic Potential 63 Orphan Designation 63 Osteoporosis Drug 63 Asthma Treatment 63 Patients Treated With 63 Investigational Agent 63 Topical Treatment 63 Initiates Phase II 63 Collaborators Present 63 Generic Versions 63 Product Designation 63 Presents Positive 63 Receives Fast Track 63 Ebola Vaccine 63 Investigational Drug 63 Initiates Enrollment 63 Combination REOLYSIN R 63 Receives Positive Opinion 63 Fungal Infections 63 HIV Integrase 63 Phase 2b Clinical Trial 63 Avian Flu Vaccine 63 Files Provisional 63 Rotavirus Vaccine 63 Novel Antibiotic 63 Shows Promising 63 Monoclonal Antibody 63 Erectile Dysfunction Drug 63 FDA Clears 63 FDA Orphan Drug 63 FDA Approvals 63 Demonstrates Significant 63 Milestone Payments 63 Recombinant Human 62 Tyrosine Kinase Inhibitor 62 Advanced Melanoma 62 Metabolic Disorder 62 Files Patent Application 62 Adjuvant Treatment 62 Submits Application 62 Completes Enrollment 62 DTC Eligibility 62 Confirms Efficacy 62 Vaccine Adjuvant 62 Earns Milestone Payment 62 Treating Heart Failure 62 Anti Inflammatory Drug 62 IND Filing 62 Anti Tumor Activity 62 First Patient Dosed 62 Completes Dosing 62 JAK Inhibitor 62 Darbepoetin Alfa 62 Demonstrates Improved 62 Phase 1b Clinical Trial 62 Demonstrates Positive 62 Severe Sepsis 62 Confirms Validity 62 Aptamer 62 Receives Approvable Letter 62 Phase 2b Trial 62 Orally Active 62 Molecular Diagnostic Test 62 Novel Mechanism 62 Regulatory Approvals 62 Study Demonstrates 62 Receive Milestone Payment 62 Marketing Authorization 62 Orphan Drug Status 62 Novel Therapeutic 62 Awarded Qualifying Therapeutic 62 Oligonucleotides 62 Obtains Exclusive License 62 TB Vaccine 62 Nicotine Vaccine 62 Bird Flu Vaccine 62 Flamel Technologies Announces 62 Cervical Cancer Vaccine 62 Blood Pressure Drug 62 Anticancer Drug 62 Novel Compound 62 Diamyd Medical Diamyd 62 Treating Chronic 62 Taro Receives 62 Nanophase Announces 62 Initiates Clinical Trials 62 Showed Significant 62 Submits Supplemental 62 Lung Cancer Survival 62 Improve Survival 62 Initiates Dosing 62 Anemia Drug 62 Intravenous Formulation 61 Demonstrates Potential 61 Antiviral Drugs 61 Submits Biologics License Application 61 C1 Inhibitor 61 Combination Treatment 61 Drug Resistant 61 Neural Stem Cells 61 Anthrax Vaccine 61 Initiate Clinical Trial 61 Patents Issued 61 Phase III Trials 61 Receives Marketing Authorization 61 Hematological Cancers 61 Cancer Vaccine 61 Combination Therapy 61 submitted Biologics License 61 Hepatitis B Vaccine 61 Smooth Muscle 61 Initiate Phase III 61 First Patient Enrolled 61 Pulmonary Arterial Hypertension 61 Receives CE Marking 61 Prostate Cancer Treatment 61 Commercialize 61 Antitumor 61 Biologics Manufacturing 61 FDA Okays 61 Hsp# Inhibitor 61 Demonstrate Significant 61 BioSante Pharmaceuticals Announces 61 Reports Preclinical Data 61 Gastrointestinal Disorders 61 NASDAQ Delisting Notice 61 Treatment Experienced 61 Cholesterol Drug 61 Shows Promise 61 Fondaparinux 61 SBIR Grant 61 Blood Clotting 61 siRNA Delivery 61 Therapeutic Antibodies 61 Drug Fails 61 Breast Tumor 61 Pafuramidine 61 Announces FDA Clearance 61 Achieves Significant 61 Effectively Treats 61 Meningitis Vaccine 61 Vaccine Adjuvants 61 Multiple Myeloma Patients 61 Biomarker Study 61 Immune Cell 61 Protease Inhibitor 61 Combo Therapy 61 Receives Complete Response 61 Receives SFDA Approval 61 StaphVAX R 61 Efficacy Trial 61 Antitumor Activity 61 Lung Cancer Trial 61 Minimally Invasive Treatment 61 Commercialize Novel 61 HCV Protease Inhibitor 61 rPA Anthrax Vaccine 61 Tumor Growth 61 Nasal Powder 61 Proves Effective 61 Gastric Cancer 61 Rheumatoid Arthritis Patients 61 Patent Issuance 61 Million Milestone Payment 61 Miraculins Announces 60 Marketing Authorisation 60 Oral Insulin 60 Schizophrenia Treatment 60 Technological Advances 60 Treatment Reduces 60 Receives Notice 60 microRNA Therapeutics 60 Phase 2a Clinical Trial 60 Final Approval 60 Testosterone Patch 60 Significant Improvements 60 WorldHeart Announces 60 Receives FDA Clearance 60 Novel Treatments 60 Capsules CII 60 Dry Powder Inhalers 60 Mesothelioma Treatment 60 Orphan Drug designation 60 Enrolling Patients 60 Clinical Trial Evaluating 60 Proven Effective 60 Develops Novel 60 NYSE Amex Listing 60 Breast Cancer Recurrence 60 BioElectronics Announces 60 Shingles Vaccine 60 Newly Identified 60 Therapeutic Vaccines 60 Blood Thinner 60 Anti Angiogenesis 60 Patent Filing 60 Sign Licensing Agreement 60 Ovarian Cancer Treatment 60 Cancer Treatments 60 SFDA Approval 60 Announce License Agreement 60 Nano Scale 60 Influenza Vaccine 60 Advanced Colorectal Cancer 60 Announces Initiation 60 Recombinant Protein 60 Autoimmune Diseases 60 Submits Response 60 Shows Efficacy 60 Licenses Novel 60 Clinical Trial Data 60 Long Term Efficacy 60 Regenerative Cells 60 Tuberculosis Vaccine 60 Novel Inhibitor 60 Inhaled Insulin 60 Measles Vaccine 60 Investigational Treatment 60 Receives Notification 60 Achieves Primary Endpoint 60 Achieves Milestone 60 Submits IND 60 Prostate Cancer Patients 60 Patent Filings 60 Equity Funds Declare 60 Significantly Reduces 60 GATTEX TM 60 Complicated Skin 60 Ephedra Ban 60 Therapeutic Monoclonal Antibodies 60 Presents Positive Preclinical 60 Osteoarthritis Patients 60 Pivotal Trial 60 Nasdaq Deficiency Notice 60 Therapeutic Vaccine 60 Therapeutic Antibody 60 Metastatic Colorectal Cancer 60 STERIS Corporation Announces 60 Drug Shows Promise 60 Rotavirus Vaccines 60 Beta Blocker 60 Atopic Dermatitis 60 Favorable Ruling 60 Relapsing Multiple Sclerosis 60 Genes Involved 60 Brain Plasticity 60 Accelerated Approval 60 Low Dose 60 Pivotal Phase 60 Myelodysplastic Syndromes 60 Stakeholder Opinions 60 Patent Upheld 60 Study Showed 60 Trial Evaluating 60 Well Tolerated 60 Kinase Inhibitor 60 Potential Dangers 60 Structural Changes 60 Announces Issuance 60 BioElectronics Corporation Announces 60 Immune Responses 60 Protein Involved 60 InNexus Biotechnology 60 Drug Approvals 60 AVI BioPharma Announces 60 TriCo Bancshares Announces 60 Gene Variant 60 Nanoemulsion 60 RNA Interference RNAi 59 Enrolls First 59 Obtains License 59 Survival Benefit 59 Kinase Inhibitors 59 Pluristem Therapeutics 59 Left Atrial 59 Improve Outcomes 59 Osteoporosis Treatment 59 Clinical Outcome 59 Statistically Significant 59 Aloxi ® 59 Demonstrates Efficacy 59 Carboplatin Paclitaxel 59 AVANIR Pharmaceuticals Announces 59 Accelerate Commercialization 59 Antibody Discovery 59 Liver Toxicity 59 Civacir 59 Chemotherapy Regimen 59 Taxane 59 Demonstrates Potent 59 Scientists Identify 59 Muscle Wasting 59 Neural Stem Cell 59 Hepatitis C Treatment 59 Appears Safe 59 Poniard Pharmaceuticals Announces 59 Weight Loss Drug 59 Ticker Symbol Change 59 Anti Inflammatory 59 Tezampanel 59 oligonucleotides Manoharan 59 Conditional Approval 59 Wound Dressings 59 Reacquires 59 Supplemental Biologics License Application 59 Targeted Therapies 59 Arthritis Drugs 59 Romiplostim 59 VIVUS Announces 59 Flexpoint Announces 59 PDL BioPharma Announces 59 Recommends Approval 59 BiTE Antibody 59 Immunosuppressant 59 Lanthanum Carbonate 59 Successfully Completes Phase 59 Data Indicate 59 Guidelines Issued 59 Antibody Drug Conjugate 59 Hospital Acquired Pneumonia 59 Vascular Targeting Agents 59 Antidepressant Drug 59 Novel Protein 59 Induces 59 Inhaled Liposomal Ciprofloxacin 59 Uses Thereof 59 Preclinical Efficacy 59 Generic Version Of 59 Anticancer Activity 59 Antibiotic Resistant 59 Patents Upheld 59 Presents Preclinical 59 Novel Approaches 59 Patent Infringement Litigation 59 Oral Interferon 59 Study Evaluating 59 Initiate Phase 59 Issues Guidance 59 Being Studied 59 Companion Diagnostic 59 Pending Acquisition 59 Immune Mediated 59 Clinical Efficacy 59 Expedited Review 59 Phase IIa Clinical Trial 59 Brain Tumor Therapy 59 Announces Presentation 59 Treatment Resistant 59 Begins Dosing 59 Provides Updates 59 FDA Approves 59 Biopharmaceutical Industry 59 Treatment Naïve 59 Drug Makers 59 SHIRE PLC 59 Biotech Firm 59 Tumor Cells 59 Ranolazine 59 Antisense Oligonucleotides 59 VIVITROL ® 59 Pediatric Patients 59 Inflammatory Arthritis 59 Researchers Identify 59 Human Monoclonal Antibodies 59 Cholesterol Drugs 59 Chronic Inflammation 59 Small Molecule Drug 59 Successful Completion 59 Improved Survival 59 II Clinical Trial 59 Bone Marrow Stem Cells 59 Patented Technology 59 Misonix Announces 59 Monoclonal Antibodies 58 Diagnostic Tests 58 Therapeutic Discovery 58 Release Capsules 58 Renal Cancer 58 Demonstrates Sustained 58 First Patient Treated 58 Nasdaq Delisting Notice 58 Derma Sciences Announces 58 Dalbavancin 58 candidates Azedra 58 Patent Infringement Lawsuit 58 Reduces Risk 58 Enters Into Collaboration 58 Sagent Pharmaceuticals Announces 58 Synthetic Peptide 58 Pneumonia Vaccine 58 Angiogenic 58 Improves Outcomes 58 Receives Favorable 58 Demonstrates Statistically Significant 58 JAK2 Inhibitor 58 Patent Lawsuit 58 Initiates Phase 58 Progenitor Cells 58 Guidelines Recommend 58 Marketing Authorisation Application 58 Genetic Testing 58 Immune Cells 58 Nerve Regeneration 58 Molecular Diagnostic 58 Regains NASDAQ 58 Tentative Approval 58 NASDAQ Deficiency Notice 58 Signaling Pathways 58 Pivotal Clinical Trial 58 Methylnaltrexone 58 Plaque Psoriasis 58 Pandemic Influenza Vaccine 58 Protein Synthesis 58 Provides Update Regarding 58 Cancer Vaccines 58 Significant Milestones 58 Hematological Malignancies 58 Non Invasive 58 Shows Promise Against 58 ARRY # 58 Regains Full 58 Files Investigational 58 Noninvasive Prenatal 58 Protein Biomarker 58 Antimicrobial Coating 58 Pharmacogenomic 58 Experimental Vaccine 58 AnaSpec Introduces 58 pralatrexate injection folate analogue 58 Influenza Vaccine Production 58 Resubmission 58 Radiopharmaceutical 58 Granulocyte Colony Stimulating Factor 58 Antifungal 58 Chemotherapeutic Agents 58 Conjugate 58 Companion Diagnostics 58 Milestone Payment From 58 Receives Regulatory 58 HDAC Inhibitor 58 Recurrent Breast Cancer 58 Acne Drug 58 Pneumococcal Vaccine 58 Antiviral Agents 58 ANDA Filing 58 Genetic Disorder 58 Live Attenuated 58 Radiation Induced 58 Molecular Pathogenesis 58 Receptor Agonist 58 Fast Track Designation 58 Clinical Evaluation 58 Confirmatory Phase 58 Golimumab 58 KEMET Announces 58 FDA Panel Recommends 58 Voluntary Withdrawal 58 Oracea TM 58 entitled Compositions 58 ARIXTRA R 58 Proposed Rule Changes 58 Completes Patient Enrolment 58 Study Shows Benefits 58 Expand Collaboration 58 Blood Thinning 58 Long Term Survival 58 Anti CD# Antibody 58 Provides Guidance 58 Announces Tentative Approval 58 Gets FDA Clearance 58 Patients Enrolled 58 Cell Transplant 58 Purported Class 58 Patients Treated 58 Thrombin topical Recombinant 58 Prophylactic Treatment 58 Generex Biotechnology 58 Toxicogenomics 58 Stent Coating 58 Commences Phase III 58 Prolongs Life 58 Antiviral Drug 58 Milestone Reached 58 Skeletal Muscle 58 Molecular Mechanisms 58 Potent Antiviral Activity 58 Regulatory Clearance 58 Dupuytren Contracture 58 Autologous Stem Cell Transplantation 58 GTC recombinant form 58 Hepatocellular Carcinoma 58 PharmaVitae Profile 58 Inovio Pharmaceuticals 58 Markets Examine 58 Signaling Pathway 58 Receives Commitment 58 Obtains Approval 58 Dendritic Cells 58 DNA Methylation 58 Awarded Patent 58 Advanced Prostate Cancer 58 Postmenopausal Osteoporosis 58 Preterm Labor 58 Novel Therapies 58 Human Neural Stem 58 Stent Placement 58 Receives Tentative Approval 57 CE marked PROGENSA 57 Obtains Exclusive Rights 57 Treatment Regimen 57 Invasive Fungal Infections 57 PRN FDA Approves 57 Protein Linked 57 Reveals Significant 57 Mimetics 57 Inhaled Nitric Oxide 57 Vaccine Protects Against 57 Cord Blood Banking 57 Migraine Treatment 57 CysDisplay R 57 Autoimmune Disorders 57 Potentially Fatal 57 No. #.# 57 Emerging Therapies 57 Etanercept 57 Risks Posed 57 SABER ™ 57 Announce Collaboration Agreement 57 Breast Cancer Treatment 57 Whole Genome Sequencing 57 Key Milestones 57 Further Validates 57 Alnylam Pharma 57 Bazedoxifene 57 Study Reinforces 57 NMDA Receptor 57 Anticoagulant 57 ADHD Medication 57 Ecallantide 57 Proves Successful 57 Valortim TM 57 Nasdaq Listing Requirements 57 Orphan Drug Designation 57 Announce Commencement 57 Flagship Product 57 Medicure Announces 57 Anworth Announces 57 Preclinical Models 57 Obtains Patent 57 Cell Proliferation 57 Chronic Hepatitis B 57 rolling Biologics License 57 Structure Function 57 Breast Cancer Stem Cells 57 Adjuvant Therapy 57 Sustained Efficacy 57 Gene Silencing 57 Transdermal Patch 57 Announce Receipt 57 Myeloma Patients 57 Phase III Clinical Trials 57 Viral Suppression 57 Demonstrates Long Term 57 Mouse Model 57 TRANSDUR ™ 57 Embryonic Stem Cells 57 Listing Compliance 57 Interferon Alpha 57 Biosimilar 57 Crowflight Announces 57 Gene Variation 57 ENLIGHT 57 Therapeutic Efficacy 57 Ustekinumab 57 Stem Cell Patents 57 Detection Device 57 Hepatitis C Virus 57 Cancer Therapies 57 Antigen Specific 57 OTC MNDP 57 Immunotherapeutic 57 Rapid Expansion 57 Heartburn Drugs 57 Preotact R 57 Leukemia Cells 57 Subgroup Analysis 57 Nasdaq Notice Regarding 57 FOLOTYN ® 57 Autoimmune Disease 57 Diet Pill 57 Brain Cells 57 Preclinical Study 57 Patients Suffering 57 Protein Expression 57 Expert Discusses 57 BioDelivery Sciences Announces 57 Patent Reexamination 57 Unfractionated Heparin 57 Drug Coated Stent 57 Holds Promise 57 Cell Differentiation 57 Viral Disease 57 Tissue Repair 57 Hypertensive Patients 57 Biologic Drugs 57 Intellectual Property Portfolio 57 Novel Anti Inflammatory 57 Widely Used 57 Sustained Release 57 Sapacitabine 57 Advisers Urge 57 ORADUR ® 57 Transcept Pharmaceuticals 57 FDA Approval 57 NeutroPhase TM 57 Nitazoxanide 57 Multicenter Trial 57 Adjuvanted 57 Antiviral Therapeutics 57 Vicriviroc 57 Awarded Patents 57 Lowers Risk 57 Extended Release 57 Sinus Infections 57 Test Detects 57 Multi Billion Dollar 57 DARA logo 57 Dual Listing 57 Receives Approval From 57 Certain Cancers 57 Begins Shipment 57 Obtains CE Mark 57 Stem Cell Differentiation 57 Cardiovascular Monitoring 57 Viral Infections 57 KL4 Surfactant 57 Hormonal Therapy 57 Malignant Glioma 57 External Defibrillators 57 Tissue Engineered 57 Suppresses 57 Patent Validity 57 Regulatory Approval 57 Identifies Potential 57 Advanced Pancreatic Cancer 57 Diabetic Nephropathy 57 Tomorrow Cures 57 NASDAQ Delisting 57 Temporarily Suspends 57 Cancer Stem Cells 57 Kidney Function 57 Antiepileptic Drug 57 Biotech Crops 57 Formalizes 57 Immune Therapy 57 Tablet Formulation 57 RECOTHROM R 57 Diabetic Patients 57 Inflammatory Disease 57 Insulin Sensitivity 57 Orphan Drug designations 57 Fixed Dose Combination 57 Shows Statistically Significant 57 Genetic Mutation 57 BioSante Pharmaceuticals Reports 57 Allergic Rhinitis 57 Adjunctive Therapy 57 Commence Phase 57 Non Invasive Treatment 57 Treated Patients 57 Metabolic Disease 57 Marketing Authorization Application 57 Nasdaq HALO 57 Receives NASDAQ 57 Gene Mutation 57 R lenalidomide 56 Balance Sheet Restructuring 56 Orphan Drugs 56 Antitrust Clearance 56 Metabolomics 56 Personalised Medicine 56 Genetic Tests 56 OTCBB ILNS 56 Tesamorelin 56 Counterfeit Drugs 56 Acute Heart Failure 56 Spectrum Pharmaceuticals Announces 56 Antisense Drug 56 Significantly Expand 56 Corneal Transplant 56 Pluripotent Stem Cells 56 Quarterly Distributions 56 Approvable 56 Xcytrin R 56 OTCBB IMUC 56 Sunesis Pharma 56 Commercialization Agreement 56 Novel Method 56 Biologic License Application 56 Sublicense 56 Textile Quotas 56 Coronary Arteries 56 Antiangiogenic 56 Hip Implants 56 ELADUR ™ 56 Pandemic Influenza Vaccines 56 Drug Formulation 56 Pirfenidone 56 Helps Predict 56 Acute Attacks 56 Antipsychotic Medications 56 Study Evaluates 56 Million Doses 56 Dry Powder Inhaler 56 Shown Effective 56 Viral Infection 56 Extended Release Capsules 56 Patent Infringement Lawsuit Against 56 Crucell Announce 56 Ridaforolimus 56 Qualified Therapeutic Discovery 56 Cethromycin 56 Proxy Proposals 56 Japanese Encephalitis Vaccine 56 Patient Dosing 56 ONGLYZA TM 56 Stomach Cancer 56 Drug Eluting Coronary Stent 56 Explore Strategic Alternatives 56 BIOLASE Announces 56 Randomized Study 56 Aurora Kinase 56 Endovascular Treatment 56 HuCAL GOLD R 56 GTC recombinant human 56 Moves Towards 56 Antipsychotic Drug 56 Stereotaxis Announces 56 Unsolicited Tender Offer 56 Transdermal Delivery 56 Contrast Agent 56 Pandemic Flu Vaccine 56 Enlarged Prostate 56 Panel Advises 56 Preliminary Injunction Against 56 Adenoma 56 Daptomycin 56 Adult Stem Cell Therapy 56 Genentech Provides Update 56 Bosutinib 56 NMT Medical Announces 56 Tumor Suppressor 56 Generic Lovenox 56 Reveals Positive 56 Patentability 56 Statin Drugs 56 Receives Clearance 56 NYSE Amex RGN 56 AdvanSource Biomaterials Announces 56 R bendamustine hydrochloride 56 Implant Sciences Receives 56 Report Analyzes 56 Sanvar R 56 Develop Next Generation 56 Levels Linked 56 Regains Compliance 56 Toxicity Testing 56 Long Term Outcomes 56 Debt Tender Offers 56 Glatiramer Acetate 56 Orphan Drug status 56 Genotyping Test 56 Resubmits 56 Dose Ranging Study 56 Swine Flu Vaccines 56 Antimalarial 56 Maribavir 56 Hematopoietic Stem Cell Transplantation 56 Aliskiren 56 Antibiotic Use 56 Cancer Biomarkers 56 Therapy Improves 56 Flagstone Re Announces 56 Patent Lawsuit Against 56 Nasdaq Delisting Notification 56 Antithrombin 56 Atypical Antipsychotic 56 Agonist MABA program 56 Immunomodulatory 56 CYOE 56 Detect Cancer 56 Heart Stents 56 Priority Review 56 Inflammatory Response 56 NASDAQ Listing Requirements 56 Bucindolol 56 Improve Diagnosis 56 SARS Virus 56 Successfully Treated 56 MEK Inhibitor 56 Patent Application 56 Receives Approvals 56 Tighter Controls 56 Sign License Agreement 56 Desvenlafaxine Succinate 56 Asthma Medication 56 Subsidiary Enters 56 Antiplatelet 56 Pharmacokinetic Study 56 Critically Ill Patients 56 Commences Phase 56 Diabetic Neuropathy 56 Laryngeal Cancer 56 Spears Conservatorship 56 Personalized Immunotherapy 56 Cytotoxicity 56 visit http:/www.mannkindcorp.com 56 Initiates Phase 2b 56 Extends Collaboration 56 Supernus Pharmaceuticals 56 Virus Infection 56 Panel Backs 56 Pharmacologic Treatment 56 Files Patent 56 Commercializes 56 Genes Linked 56 Submits Proposal 56 Pathogen Detection 56 SABESP Announces 56 Breast Cancer Metastasis 56 Diagnosis Treatment 56 Protein Therapeutics 56 Multicenter Randomized 56 Disease Modifying 56 Epidermal Growth Factor Receptor 56 Versus Placebo 56 Pivotal Trials 56 Successfully Completed 56 Data Exclusivity 56 Gene Expression Analysis 56 Insulin Resistance 56 Hematological 56 Reports Positive 56 Nucleic Acids 56 Preterm Delivery 56 Abortion Pill 56 IIa Clinical Trial 56 AZoNano.com #/#/# 56 Pivotal Phase II 56 Crit Rev 56 Inherited Diseases 56 Initiate Phase II 56 FDA Approvable Letter 56 Fuwei Films Announces 56 Inflammatory Markers 56 See CLINICAL PHARMACOLOGY 56 Wound Dressing 56 rxRNA 56 Reconfirms 56 ViRexx Announces 56 Mad Cow Case 56 Dramatically Increases 56 Mad Cow Testing 56 Flu Vaccine 56 Drug Maker 56 Nasdaq Delisting 56 Bevacizumab 56 FDA Approves Drug 56 Eradicates 56 Receives Tentative FDA 56 Complies With 56 Diagnostic Criteria 56 Invoke Fifth Amendment 56 Prenatal Diagnosis 56 Strengthens Position 56 Swine Flu Vaccine 56 Mutually Agree 56 Ovarian Cancer Patients 56 Bare Metal Stent 56 Announces Dismissal 56 Fibromyalgia Pain 56 Less Invasive 56 Maven Semantic 56 Immunogenicity 56 Chronic Myeloid Leukemia 56 Technological Innovations 56 Anti Angiogenic 56 Unsolicited Proposal 56 FDA Cracks Down 56 Expands Scope 56 CHMP Opinion 56 Artificial Liver 56 Paliperidone ER 56 Commonly Used 55 Patent Infringement Suit 55 Idenix Novartis 55 Cell Transplants 55 Genetic Screening 55 Oral Spray 55 Stronger Warnings 55 Receives Approval 55 Clears Path 55 Significantly Increases 55 HuCAL PLATINUM R 55 Induced Pluripotent Stem Cell 55 Secondary Hyperparathyroidism 55 Radilex TM 55 Metformin HCl 55 Hematology Molecular Pathology